CFTR and cystic fibrosis: As a model we propose that mutations in CFTR disrupt cholesterol movement to the plasma membrane likely through disruption of endosomal trafficking, either directly or indirectly, which is consistent with cholesterol accumulation reported in CF cells [1-4].